3 Reasons to Buy Eli Lilly Stock

Eli Lilly (NYSE: LLY) has been one of the better-performing pharma companies of 2020. Year to date, the pharma giant's stock is up by 24.7%, while the SPDR S&P Pharmaceuticals ETF -- an industry benchmark -- is down by 5.5%.

There are several reasons Eli Lilly has been beating the market of late. The ongoing COVID-19 pandemic actually improved the company's financial performance during the first quarter. I think Eli Lilly will continue to outperform for the following three reasons. 

Continue reading

Source Fool.com